DIAGENICS has patented antibodies to this enzyme and has already developed a new product line for the early diagnosis of chest pain patients for the detection of heart attacks: DIACORDON®. Current and future studies will also expand our knowledge in the field of heart attack diagnosis and the success of the course of treatment (monitoring).
Diagenics has patented antibodies to this enzyme and has already developed a new line of products for the early diagnosis of stroke: DIASTROKE®. The product was CE registered based on a study. Future studies will expand our expertise in stroke diagnosis.